Zymeworks officer proposes $1.05M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zymeworks Inc. officer Paul Andrew Moore reported a proposed sale of 39,741 common shares, with an aggregate market value of $1,051,944.27 and an approximate sale date of November 13, 2026.
The notice lists 7,367 and 7,374 shares acquired through restricted stock unit vestings on January 5, 2024 and January 6, 2025, respectively, and 25,000 shares from an option exercise dated November 13, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
Exercise and sell to cover financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.